1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Sato, A. Kawaguchi, K. Kimura, K. Tanimura, R. Sone, S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 A peptide mimetic of IFN, the first proof of a small peptidic agonist for heterodimeric cytokine receptor 10.2210/pdb1id7/pdb pdb_00001id7 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 1784.942 SYR6 1 syn polymer no no SVQARWEAAFDLDLY SVQARWEAAFDLDLY A polypeptide(L) n n n n n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2002-04-10 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession 1ID6 contains the origninal 11 structures which were used for calculation of this average structure. RCSB Y PDBJ 2001-04-04 REL REL chemically synthesized sample This structure was determined using standard 2D homonuclear techniques. Average structure of the 11 structures with the least restraint violations 750 1 DQF-COSY TOCSY 2D NOESY ambient 293 K The average structure of the 11 structures that are based on 66 NOE-derived distance constraints. 4D simulated annealing 1 minimized average structure 2.0mM SYR6; deuterated dimethyl sulfoxide 100% deuterated dimethyl sulfoxide 100% Morikawa, S. et. al. structure solution EMBOSS 5.0 Morikawa, S. et. al. refinement EMBOSS 5.0 600 Varian INOVA n 1 1 A VAL 2 n 2 VAL 2 A GLN 3 n 3 GLN 3 A ALA 4 n 4 ALA 4 A ARG 5 n 5 ARG 5 A TRP 6 n 6 TRP 6 A GLU 7 n 7 GLU 7 A ALA 8 n 8 ALA 8 A ALA 9 n 9 ALA 9 A PHE 10 n 10 PHE 10 A ASP 11 n 11 ASP 11 A LEU 12 n 12 LEU 12 A ASP 13 n 13 ASP 13 A n 14 14 A n 15 15 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A SER 1 A SER 1 1 Y 1 A LEU 14 A LEU 14 1 Y 1 A TYR 15 A TYR 15 1 Y 1 A ALA 4 -13.94 1 A GLN 3 -136.05 -38.54 1 A ALA 4 58.58 -177.09 1 A ARG 5 34.15 37.81 1 A TRP 6 -145.62 -150.46 1 A GLU 7 -36.87 -35.46 1 A ALA 8 -156.57 -82.21 1 A ALA 9 164.58 145.15 1 A PHE 10 -124.56 -88.31 minimized average SOLUTION STRUCTURE OF SYR6 1 N N ANTIVIRAL PROTEIN SYR6, ANTIVIRAL PROTEIN BAB62415 GB 1 15076606 1 15 1ID7 1 15 15076606 A 1 1 15